中文名稱:化合物 LT175 | 英文名稱:LT175 |
CAS:862901-87-9 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
產(chǎn)品類別: 抑制劑 | |
貨號(hào): T21812 |
名稱 | LT175 |
描述 | LT175, a dual PPARα/γ ligand, demonstrates potent insulin-sensitizing effects while exhibiting reduced adipogenic properties. This compound is an orally active partial agonist targeting PPARγ, with EC50 values of 0.22 μm for hPPARα, 0.26 μm for mPPARα, and 0.48 μm for hPPARγ. LT175 specifically interacts with PPARγ, influencing the recruitment of coregulators such as the cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). Additionally, LT175's interaction with PPARγ occurs within a hydrophobic region known as the "diphenyl pocket" [1]. |
體內(nèi)活性 | LT175 (100 mg/kg/day; orally; for 3 days) significantly reduce the body weight (11%) and reduces fasting blood glucose, triglycerides, and free fatty acids. LT175 decreases total plasma cholesterol significantly in diet-induced Insulin-resistant mice (six-week-old C57Bl/6J male mice) [1]. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
關(guān)鍵字 | LT 175 | LT-175 | LT175 |
成立日期 | 2013-04-18 (13年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP1年
|
青島愷潤生物醫(yī)藥科技有限公司
|
2025-07-17 | |
詢價(jià) |
上海貝鑫科科技發(fā)展有限公司
|
2025-07-31 | ||
詢價(jià) |
VIP3年
|
陜西西化化學(xué)工業(yè)有限公司
|
2025-07-29 |